Founder, President and Chief Scientific Officer

Dr. Grammer is a Biotech Executive and NIH-trained Scientist-Entrepreneur (Immunology, Genomics, Pharmacology, ML/PredictiveAI) who has successfully translated her discoveries into a precision health business with prognostic tests for patients and monitoring biomarkers for pharma.  This year her company AMPEL BioSolutions launched the LuGENE^® blood test to predict flares and abnormal drug targets for Lupus patients that is being highlighted by the Lupus Foundation of America, Lupus News Today & business organizations alike.  News outlets (NPR RadioIQ, GenomeWeb, CBS19, Helio, Scripps News Network) are covering the breakthrough.  Dr. Grammer’s business accomplishments & leadership have been spotlighted by CBIC Innovator-of-the-Year 2023, VTOP Workforce & Virginia Catalyst.  Dr. Grammer and AMPEL have been nationally recognized including ranking by Nature in the top five precision medicine companies by impact of science (FoundationMed, Illumina, Tempus, ThermoFisher), election to the Federal ARPA-H Customer Experience Health Network, 21st Century Precision Med Coalition and invitation for 5+ years to the LaGuna CEO conference organized by Brook Byers.